Credit: Jackyenjoyphotography / Moment / Getty Images Celonic, a Swiss-based biologics CDMO, and Leukocare, which provides drug product development services,…
Newly published work in Neuro-Oncology spotlights a molecular vulnerability in glioblastoma (GBM), the most aggressive primary brain tumor. The study,…